Back to top
more

Medtronic (MDT)

(Real Time Quote from BATS)

$91.63 USD

91.63
1,878,933

-1.11 (-1.20%)

Updated Aug 12, 2025 01:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (145 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Hold on to Varian (VAR) Stock for Now

by Zacks Equity Research

Varian (VAR) gains from Oncology unit, deals with weakness in the Proton Therapy segment.

Zacks Equity Research

Medtronic (MDT) Beats on Q2 Earnings, Ups FY20 EPS Guidance

by Zacks Equity Research

Medtronic (MDT) demonstrates improved performances at CER, banking on growth in all major business segments and geographies.

Zacks Equity Research

Zacks.com featured highlights include: Medtronic Public, Arconic, Nasdaq, Hewlett Packard and Target

by Zacks Equity Research

Zacks.com featured highlights include: Medtronic Public, Arconic, Nasdaq, Hewlett Packard and Target

Zacks Equity Research

Medtronic (MDT) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Medtronic (MDT) delivered earnings and revenue surprises of 2.34% and 0.38%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Medtronic (MDT) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

In the fiscal second quarter, Medtronic (MDT) is expected to have registered strong growth in its ICD and CRT product lines.

Zacks Equity Research

5 Stocks Trading Near 52-Week High With More Room to Run

by Zacks Equity Research

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

Zacks Equity Research

Here's Why You Should Add NuVasive (NUVA) to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about NuVasive's (NUVA) stellar performance.

Zacks Equity Research

Medtronic (MDT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Medtronic (MDT) Releases Positive Study Results on Pacemaker

by Zacks Equity Research

Medtronic (MDT) presents favorable results from study on leadless pacemaker, indicating potential for improving cardiac functions in patients having blockages.

Zacks Equity Research

Medtronic (MDT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed at $107.97 in the latest trading session, marking a +0.88% move from the prior day.

Zacks Equity Research

Medtronic (MDT) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed at $105.53 in the latest trading session, marking a -1.51% move from the prior day.

Zacks Equity Research

United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up

by Zacks Equity Research

United Therapeutics (UTHR) beats estimates on both fronts in the third quarter. Stock rises in response

Zacks Equity Research

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed at $108.55 in the latest trading session, marking a +0.93% move from the prior day.

Zacks Equity Research

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed the most recent trading day at $105.21, moving -0.01% from the previous trading session.

Zacks Equity Research

Quest Diagnostics (DGX) Q3 Earnings Surpass, View Strong

by Zacks Equity Research

We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to accelerate volume growth in Q3.

Zacks Equity Research

Zacks.com featured highlights include: Target, Owens Corning, Booz Allen Hamilton, Medtronic and Dick's Sporting Goods

by Zacks Equity Research

Zacks.com featured highlights include: Target, Owens Corning, Booz Allen Hamilton, Medtronic and Dick's Sporting Goods

Trina Mukherjee headshot

Medical Products Industry Outlook: Prospects Seem Promising

by Trina Mukherjee

Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.

Sweta Killa headshot

5 Solid Dividend Growth Stocks for Higher Returns

by Sweta Killa

Stocks with a strong history of dividend growth year over year form a healthy portfolio with a greater scope of capital appreciation.

Urmimala Biswas headshot

3 Medical Product Stocks Likely to Beat This Earnings Season

by Urmimala Biswas

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Zacks Equity Research

Intuitive Surgical (ISRG) Beats on Q3 Earnings, View Solid

by Zacks Equity Research

Intuitive Surgical (ISRG) gains from solid segmental contributions in Q3.

Zacks Equity Research

Medtronic (MDT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Medtronic (MDT) closed at $108.50 in the latest trading session, marking a +0.29% move from the prior day.

Zacks Equity Research

Philips Boosts Stellarex Portfolio, Expands in Healthcare

by Zacks Equity Research

Phillips (PHG) bolsters presence in Diagnosis & Treatment business with new low-dose drug-coated balloons.

Zacks Equity Research

Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance

by Zacks Equity Research

We are optimistic about Abbott's (ABT) strong and consistent EPD and Medical Devices performance organically.

Zacks Equity Research

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about IDEXX's (IDXX) performance.

Zacks Equity Research

Has Medtronic (MDT) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (MDT) Outperforming Other Medical Stocks This Year?